These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7634615)

  • 21. Adhesion molecules as targets for cancer therapy.
    Huang YW; Baluna R; Vitetta ES
    Histol Histopathol; 1997 Apr; 12(2):467-77. PubMed ID: 9151136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoblasts suppress high bone turnover caused by osteolytic breast cancer in-vitro.
    Krawetz R; Wu YE; Rancourt DE; Matyas J
    Exp Cell Res; 2009 Aug; 315(14):2333-42. PubMed ID: 19433087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.
    Yoneda T; Michigami T; Yi B; Williams PJ; Niewolna M; Hiraga T
    Cancer Treat Rev; 1999 Oct; 25(5):293-9. PubMed ID: 10544073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic bone disease induced by prostate cancer: rationale for the use of bisphosphonates.
    Berruti A; Dogliotti L; Tucci M; Tarabuzzi R; Fontana D; Angeli A
    J Urol; 2001 Dec; 166(6):2023-31. PubMed ID: 11696699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.
    Pluijm G; Löwik C; Papapoulos S
    Cancer Treat Rev; 2000 Feb; 26(1):11-27. PubMed ID: 10660489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
    Lipton A
    J Support Oncol; 2004; 2(3):205-13; discussion 213-4, 216-7, 219-20. PubMed ID: 15328823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of invasion and metastasis in human neuroblastoma.
    Ara T; DeClerck YA
    Cancer Metastasis Rev; 2006 Dec; 25(4):645-57. PubMed ID: 17160711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
    Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
    Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of bone invasion and metastasis in human neuroblastoma.
    Sohara Y; Shimada H; DeClerck YA
    Cancer Lett; 2005 Oct; 228(1-2):203-9. PubMed ID: 15975706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms and treatment of bone metastasis.
    Clines GA; Guise TA
    Expert Rev Mol Med; 2008 Mar; 10():e7. PubMed ID: 18321396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local effects of malignancy on bone.
    Brown SA; Clines GA; Guise TA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):436-41. PubMed ID: 17982348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.
    Sanderson RD; Yang Y; Suva LJ; Kelly T
    Matrix Biol; 2004 Oct; 23(6):341-52. PubMed ID: 15533755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.
    Morony S; Capparelli C; Sarosi I; Lacey DL; Dunstan CR; Kostenuik PJ
    Cancer Res; 2001 Jun; 61(11):4432-6. PubMed ID: 11389072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [When and why does cancer metastasize? An overview of current viewpoints OF the molecular mechanism of invasiveness].
    Mareel M
    Verh K Acad Geneeskd Belg; 1994; 56(2):105-25. PubMed ID: 8048267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
    Vessella RL; Corey E
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6285s-6290s. PubMed ID: 17062715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S; Ehrlich LA; Roodman GD
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone cancer pain and the role of RANKL/OPG.
    Clohisy DR; Mantyh PW
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):293-300. PubMed ID: 15615497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone cancer pain.
    Clohisy DR; Mantyh PW
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S279-88. PubMed ID: 14600620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.